Five Prime Therapeutics Inc
COMBINED ANTI TUMOR THERAPY WITH A GITR AGONIST AND CPG

Abstract:

The present disclosure relates to methods of using glucocorticoid-induced TNFR-related protein (GITR) agonists as anti-tumor agents, for example in combination with CpG oligodeoxynucleotides. A specific antibody, characterized by its CDRs is described as agonist.